These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 7880176)
1. [Preparation and characteristics of a tritiated derivative of CP-96,345--a nonpeptide antagonist of the substance P receptor with a high specific radioactivity]. Kasheverov IE; Zaĭtsev DA; Utkin IuN; Tsetlin VI Bioorg Khim; 1994 Nov; 20(11):1162-8. PubMed ID: 7880176 [TBL] [Abstract][Full Text] [Related]
2. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs. Chahl LA; Johnston PA Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540 [No Abstract] [Full Text] [Related]
3. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels. Schmidt AW; McLean S; Heym J Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177 [TBL] [Abstract][Full Text] [Related]
4. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites. Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942 [TBL] [Abstract][Full Text] [Related]
5. (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation. Karlsson U; Näsström J; Berge OG Regul Pept; 1994 Jun; 52(1):39-46. PubMed ID: 7972930 [TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist. MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630 [TBL] [Abstract][Full Text] [Related]
7. Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345. De Sanctis GT; Green FH; Jiang X; King M; Remmers JE J Appl Physiol (1985); 1994 Apr; 76(4):1528-32. PubMed ID: 7519186 [TBL] [Abstract][Full Text] [Related]
8. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708. Sachais BS; Krause JE Mol Pharmacol; 1994 Jul; 46(1):122-8. PubMed ID: 8058046 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and neurokinin antagonist activity of 2-benzylidene- and 2-benzyl-3-benzylamino quinuclidines. Caliendo G; Greco G; Perissutti E; Santagada V; Silipo C; Vittoria A; Turbanti L; Renzetti AR; Benedetti E; Pedone C Farmaco; 1993 Oct; 48(10):1359-78. PubMed ID: 8117379 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan. MacLeod AM; Cascieri MA; Merchant KJ; Sadowski S; Hardwicke S; Lewis RT; MacIntyre DE; Metzger JM; Fong TM; Shepheard S J Med Chem; 1995 Mar; 38(6):934-41. PubMed ID: 7535362 [TBL] [Abstract][Full Text] [Related]
11. Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation. Nagahisa A; Asai R; Kanai Y; Murase A; Tsuchiya-Nakagaki M; Nakagaki T; Shieh TC; Taniguchi K Regul Pept; 1993 Jul; 46(1-2):433-6. PubMed ID: 7692559 [No Abstract] [Full Text] [Related]
12. Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligand. Rosen T; Seeger TF; McLean S; Desai MC; Guarino KJ; Bryce D; Pratt K; Heym J; Chalabi PM; Windels JH J Med Chem; 1993 Oct; 36(21):3197-201. PubMed ID: 7693945 [TBL] [Abstract][Full Text] [Related]
13. Tachykinins, via NK1 receptor activation, play a relevant role in plasma protein extravasation evoked by allergen challenge in the airways of sensitized guinea-pigs. Bertrand C; Geppetti P; Baker J; Yamawaki I; Nadel JA Regul Pept; 1993 Jul; 46(1-2):214-6. PubMed ID: 7692494 [No Abstract] [Full Text] [Related]
14. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Jensen CJ; Gerard NP; Schwartz TW; Gether U Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441 [TBL] [Abstract][Full Text] [Related]
15. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity. Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies. Del Rosario RB; Mangner TJ; Gildersleeve DL; Shreve PD; Weiland DM; Lowe JA; Drozda SE; Snider RM Nucl Med Biol; 1993 May; 20(4):545-7. PubMed ID: 7684941 [TBL] [Abstract][Full Text] [Related]
17. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888. Miyayasu K; Mak JC; Nishikawa M; Barnes PJ Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449 [TBL] [Abstract][Full Text] [Related]
18. A selective and potent antagonist of substance P receptors on pancreatic acinar cells. Sjödin L; Gylfe E Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274 [TBL] [Abstract][Full Text] [Related]
19. Differential blockade by tachykinin NK1 and NK2 receptor antagonists of bronchoconstriction induced by direct-acting agonists and the indirect-acting mimetics capsaicin, serotonin and 2-methyl-serotonin in the anesthetized guinea pig. Buckner CK; Liberati N; Dea D; Lengel D; Stinson-Fisher C; Campbell J; Miller S; Shenvi A; Krell RD J Pharmacol Exp Ther; 1993 Dec; 267(3):1168-75. PubMed ID: 8263778 [TBL] [Abstract][Full Text] [Related]
20. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor. Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]